TherimuneX, with laboratories at the Pennsylvania Biotechnology Center of Bucks County in Doylestown, is developing technology relating to a new family of endogenous lipopeptides and their immune regulating properties. The TherimuneX scientific discovery has led to the development of a new therapeutic peptide for treating and preventing infectious diseases.